Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rh-bFGF topical gel for chronic cutaneous wounds
CTR20132467Phase 3Active
- Sponsor
- Nanhai Langtai Pharmaceutical
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of trafermin in diabetic foot ulcer (DFU), vascular ulcer, decubitus ulcer, traumatic ulcer, Radiation ulcer, sponsored by Nanhai Langtai Pharmaceutical. Started Jan 2014; status: active.
02
Drugs
trafermin
03
Conditions
diabetic foot ulcer (DFU)vascular ulcerdecubitus ulcertraumatic ulcerRadiation ulcer
Beyond the preview
Go deeper on CTR20132467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132467.